ÂÜÀòÂÒÂ×

Richard Pye currently serves as Chief Financial Officer at both Arcturis Data and Sensyne Health since November 2022 and November 2020, respectively. Previously, Richard Pye held multiple roles at Summit Therapeutics plc from June 2007 to June 2020, including Vice President of Corporate Affairs & Investor Relations, leveraging a strong background in biotechnology and drug development. Earlier experience includes positions at VASTox plc, transitioning from Investor Relations Manager to Senior Director of Corporate Affairs & Communications between November 2004 and May 2007, and a background as a Postdoctoral Research Associate at the University of Oxford from 2002 to 2004. Richard Pye earned a PhD in Synthetic Organic Chemistry from the University of Reading and an MChem from The University of Sheffield.